Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Epizyme Inc. (EPZM)

24.26   2.03 (9.13%) 02-14 16:00
Open: 22.83 Pre. Close: 22.23
High: 24.37 Low: 22.65
Volume: 951,361 Market Cap: 2319M
Epizyme Inc is a clinical stage biopharmaceutical company. The Company discovers, develops and commercializes novel epigenetic therapies for cancer patients.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 24.393 - 24.511 24.511 - 24.613
Low: 22.381 - 22.511 22.511 - 22.623
Close: 24.055 - 24.267 24.267 - 24.451

Technical analysis

as of: 2020-02-14 4:28:24 PM
Overall:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 32.49     One year: 37.95
Support: Support1: 23.15    Support2: 20.26
Resistance: Resistance1: 27.82    Resistance2: 32.49
Pivot: 21.96
Moving Average: MA(5): 22.74     MA(20): 22.84
MA(100): 17.30     MA(250): 14.57
MACD: MACD(12,26): 0.07     Signal(9): 0.03
Stochastic oscillator: %K(14,3): 58.09     %D(3): 41.37
RSI: RSI(14): 59.49
52-week: High: 27.82  Low: 9.74  Change(%): 99.2
Average Vol(K): 3-Month: 112356  10-Days: 62242

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
EPZM has closed above the upper band by 24.8%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 33.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2020-02-14
Stock Alert: Epizyme (EPZM)
Epizyme Inc.'s (EPZM) first drug TAZVERIK, which was granted accelerated FDA approval for the treatment of metastatic or locally advanced epithelioid sarcoma last month, will face the U.

2020-02-06
Epizyme (EPZM) Stock Sinks As Market Gains: What You Should Know
Epizyme (EPZM) closed at $21.78 in the latest trading session, marking a -0.5% move from the prior day.

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 97.74
Shares Float (M) 75.94
% Held by Insiders 0.25
% Held by Institutions 105.53
Shares Short (K) 8020
Shares Short P. Month (K)

Stock Financials

EPS -1.630
Book Value (p.s.) 2.810
PEG Ratio -0.30
Profit Margin
Operating Margin -492.91
Return on Assets (ttm) -33.5
Return on Equity (ttm) -58.8
Qtrly Rev. Growth
Gross Profit (p.s.) -0.861
Sales Per Share
EBITDA (p.s.) -1.464
Qtrly Earnings Growth
Operating Cash Flow (M) -134.24
Levered Free Cash Flow (M) -84.55

Stock Valuations

P/E -14.88
P/E Growth Ratio 0.09
P/BV 8.63
P/S 71.35
P/CF -17.66

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.